Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Administration of insulin]

E Arnould, M Mezac, M Andjelkovic

    Soins; La Revue De Reference Infirmiere
    |April 1, 1993
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ultra-Early Diffuse Lung Disease in an Infant with Pathogenic Variant in Telomerase Reverse Transcriptase (<i>TERT</i>) Gene.

    Balkan journal of medical genetics : BJMG·2024
    Same author

    Novel telomerase reverse transcriptase gene mutation in a family with aplastic anaemia.

    Familial cancer·2024
    Same author

    Urinary excretion profile of higenamine in females after oral administration of supplements - Doping scenario.

    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2024
    Same author

    [The effects of cycloplegic eyedrops on corneal tomography].

    Journal francais d'ophtalmologie·2016
    Same author

    Aleglitazar, a dual peroxisome proliferator-activated receptor-α/γ agonist, improves insulin sensitivity, glucose control and lipid levels in people with type 2 diabetes: findings from a randomized, double-blind trial.

    Diabetes, obesity & metabolism·2015
    Same author

    Efficacy, safety and tolerability of aleglitazar in patients with type 2 diabetes: pooled findings from three randomized phase III trials.

    Diabetes, obesity & metabolism·2015